| Literature DB >> 32746747 |
Linda Timm1, Katri Harcke2, Ida Karlsson1, Kristi Sidney Annerstedt1, Helle Mölsted Alvesson1, Nouha Saleh Stattin2,3, Birger C Forsberg1, Claes-Göran Östenson4, Meena Daivadanam1,5,6.
Abstract
BACKGROUND: Type 2 diabetes and its high-risk stage, prediabetes, are often undiagnosed. Early detection of these conditions is of importance to avoid organ complications due to the metabolic disturbances associated with diabetes. Diabetes screening can detect persons unaware of diabetes risk and the elevated glucose levels can potentially be reversed through lifestyle modification and medication. There are mainly two approaches to diabetes screening: opportunistic facility-based screening at health facilities and community screening.Entities:
Keywords: Community screening; FINDRISC; T2D; facility-based screening; hard-to-reach; opportunistic screening; prediabetes
Mesh:
Year: 2020 PMID: 32746747 PMCID: PMC7480601 DOI: 10.1080/16549716.2020.1795439
Source DB: PubMed Journal: Glob Health Action ISSN: 1654-9880 Impact factor: 2.640
Figure 1.Prisma flow diagram showing participants in the two screening processes.
Study setting characteristics.
| Study area | Site 1 | Site 2 | Site 3 | Site 4 |
|---|---|---|---|---|
| Total population, eligible | 18,814 | 37,549 | 27,027 | 13,292 |
| Proportion of immigrants (persons born outside Sweden) | 60% | 32% | 36% | 55% |
| Care Need Index (CNI) | 2.39 | 1.78 | 1.52 | 1.96 |
Comparison of FINDRISC characteristics between community and facility-based screening.
| Variables | Total | Community | Facility | P-value a |
|---|---|---|---|---|
| Age median (IQR) | 50 (38–61) | 48 (37–59) | 56 (43–65) | < 0.001 |
| n (%) | n (%) | n (%) | ||
| Sex | 1446 (56) | 1030 (56) | 416 (56) | 0.975 |
| BMI | 890 (35) | 692 (38) | 198 (27) | < 0.001 |
| Waist | 480 (33) | 370 (36) | 110 (26) | 0.001 |
| Physical activity 30 min/day | 1787 (70) | 1271 (70) | 516 (70) | 0.824 |
| Intake of vegetables or fruit every day | 1671 (65) | 1221 (67) | 450 (61) | 0.005 |
| Medication for high blood pressure | 606 (24) | 383 (21) | 223 (30) | < 0.001 |
| Elevated glucose values earlier in life | 485 (19) | 315 (17) | 170 (23) | 0.001 |
| Family history of diabetes | 1412 (55) | 964 (53) | 448 (61) | < 0.001 |
| Born in Europe | 989 (39) | 503 (28) | 486 (66) | < 0.001 |
| FINDRISC score | 1348 (53) | 1048 (57) | 300 (41) | < 0.001 |
| FINDRISC score median (IQR) | 11 (8–14) | 10 (7–14) | 12 (9–16) | < 0.001b |
a = P-value is calculated using Chi-squared tests for proportions, except those markedb.
b = P-value is calculated using Wilcoxon rank sum test of equality of medians.
Comparison of proportions & representativeness for the two screening methods with respect to the eligible population.
| Study site | Community screening compared with Facility-based screening | Community screening compared with eligible target population from the study areas | Facility-based screening compared with eligible target population from the study areas | ||||||
| | Community (%) | Facility (%) | P-value | Community (%) | SCB Com. (%) | P-value | Facility (%) | SCB Fac. (%) | P-value |
| Age groups | |||||||||
| Total (n) | 1822 | 737 | Chi2 | 1822 | 41979 | Pr-test | 737 | 31368 | Pr-test |
| 18–24 | 91 (5) | 19 (3) | 0.007 | 91 (5) | 5315 (13) | < 0.001 | 19 (3) | 4034 (13) | < 0.001 |
| 25–64 | 1461 (80) | 522 (71) | < 0.001 | 1461 (80) | 29539 (70) | < 0.001 | 522 (71) | 21467 (68) | 0.099 |
| 65–79 | 235 (13) | 196 (27) | < 0.001 | 235 (13) | 5575 (13) | 0.861 | 196 (27) | 4460 (14) | < 0.001 |
| 80–89 | 35 (2) | 0 (0) | 35 (2) | 1550 (4) | < 0.001 | 0 (0) | 1407 (4) | < 0.001 | |
| Sex | |||||||||
| Total (n) | 1827 | 737 | 1827 | 56363 | 737 | 40319 | |||
| Female | 1030 (56) | 416 (56) | 0.975 | 1030 (56) | 27852 (49) | < 0.001 | 416 (56) | 20059 (50) | < 0.001 |
| Male | 797 (44) | 321 (44) | 0.975 | 797 (44) | 28511 (51) | < 0.001 | 321 (44) | 20260 (50) | < 0.001 |
| Place of birth | |||||||||
| Total (n) | 1827 | 737 | 1827 | 56363 | 737 | 40319 | |||
| Africa | 564 (31) | 22 (3) | < 0.001 | 564 (31) | 6126 (11) | < 0.001 | 22 (3) | 2218 (6) | < 0.001 |
| Asia | 706 (39) | 183 (25) | < 0.001 | 706 (39) | 9031 (16) | < 0.001 | 183 (25) | 7405 (18) | < 0.001 |
| N. & C. America | 6 (0) | 5 (1) | 0.220 | 6 (0) | 308 (1) | < 0.001 | 5 (1) | 218 (1) | < 0.001 |
| S. America | 56 (3) | 46 (6) | < 0.001 | 56 (3) | 1009 (2) | < 0.001 | 46 (6) | 1067 (3) | < 0.001 |
| Europe | 132 (7) | 76 (10) | 0.010 | 132 (7) | 6844 (12) | < 0.001 | 76 (10) | 5962 (15) | < 0.001 |
| Only Sweden | 363 (20) | 405 (55) | < 0.001 | 363 (20) | 32934 (58) | < 0.001 | 405 (55) | 23359 (58) | 0.093 |
| Unknown | 91 (0) | 90 (0) | |||||||
Abbreviations:
SCB Com: Population eligible for screening from the community screening sites
SCB Fac.: Population eligible for screening from the facility-based screening sites
SCB: Statistics Sweden.